Su Seong Lee

As a Senior Scientist at the research centre of KFSHRC, he has developed a broad expertise in the field of chemistry, with a particular focus on nanomaterials, catalysts, peptide-related agents, and ligand development for targeted RNA delivery. His primary research interests include the design and synthesis of peptide-associated diagnostic agents and therapeutic drugs, as well as the creation of biomaterials. Additionally, he specializes in developing ligands that enable the precise delivery of oligonucleotide therapeutics, supporting advanced applications in targeted treatments.

Targeted theranostics.

Peptide chemistry.

Ligand for targeted oligonucleotide delivery.

Biomaterials.

Nanostructured materials.

Dr. Lee received his B.Sc., M.Sc., and Ph.D. in chemistry from Seoul National University (SNU), Korea. And then he worked as a senior research scientist at Saehan Industries Inc., where he developed electronic materials for three years. In 2000, Dr. Lee joined SNU as a postdoctoral fellow, focusing on magnetic nanoparticles and nanoporous materials. His research in nanoscience continued at MIT in 2001, where he conducted postdoctoral research under Prof. Jackie Y. Ying. After two years at MIT, Dr. Lee advanced his career at IBN, A*STAR, holding roles as senior scientist and principal research scientist from 2003 to 2019, with a focus on nanoscience and peptide chemistry. In 2019, he founded a start-up company dedicated to the development of targeted radiopharmaceuticals. Between 2020 and 2024, he researched targeted RNA delivery at NanoBio Lab and IMCB under A*STAR. In 2024, Dr. Lee joined KFSHRC as a senior scientist.